A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental Vitiligo

NCT07667569 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Segmental Vitiligo

Interventions

DRUG: ACT-777991
DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.